The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Sterile Injectable Drugs-Global Market Insights and Sales Trends 2024

Sterile Injectable Drugs-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1848604

No of Pages : 94

Ask Your Query
Synopsis
Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body.
The global Sterile Injectable Drugs market size is expected to reach US$ 5132.6 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Sterile Injectable Drugs in various end use industries. The expanding demands from the Cancer, Diabetes, Cardiovascular Diseases and Musculoskeletal, are propelling Sterile Injectable Drugs market. Cytokines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Insulin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sterile Injectable Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sterile Injectable Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sterile Injectable Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sterile Injectable Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sterile Injectable Drugs covered in this report include Baxter International, Sanofi, GlaxoSmithKline, AstraZeneca, Merck, Novartis, Pfizer, GILEAD SCIENCES and Johnson & Johnson Services, etc.
The global Sterile Injectable Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter International
Sanofi
GlaxoSmithKline
AstraZeneca
Merck
Novartis
Pfizer
GILEAD SCIENCES
Johnson & Johnson Services
Global Sterile Injectable Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sterile Injectable Drugs market, Segment by Type:
Cytokines
Insulin
Peptide hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide antibiotics
Others
Global Sterile Injectable Drugs market, by Application
Cancer
Diabetes
Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sterile Injectable Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sterile Injectable Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Sterile Injectable Drugs Market Overview
1.1 Sterile Injectable Drugs Product Overview
1.2 Sterile Injectable Drugs Market Segment by Type
1.2.1 Cytokines
1.2.2 Insulin
1.2.3 Peptide hormones
1.2.4 Vaccines
1.2.5 Immunoglobulins
1.2.6 Blood Factors
1.2.7 Peptide antibiotics
1.2.8 Others
1.3 Global Sterile Injectable Drugs Market Size by Type
1.3.1 Global Sterile Injectable Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Sterile Injectable Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sterile Injectable Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sterile Injectable Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sterile Injectable Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sterile Injectable Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sterile Injectable Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sterile Injectable Drugs Sales Breakdown by Type (2018-2023)
2 Global Sterile Injectable Drugs Market Competition by Company
2.1 Global Top Players by Sterile Injectable Drugs Sales (2018-2023)
2.2 Global Top Players by Sterile Injectable Drugs Revenue (2018-2023)
2.3 Global Top Players by Sterile Injectable Drugs Price (2018-2023)
2.4 Global Top Manufacturers Sterile Injectable Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sterile Injectable Drugs Market Competitive Situation and Trends
2.5.1 Sterile Injectable Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sterile Injectable Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sterile Injectable Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Sterile Injectable Drugs Market
2.8 Key Manufacturers Sterile Injectable Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sterile Injectable Drugs Status and Outlook by Region
3.1 Global Sterile Injectable Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sterile Injectable Drugs Historic Market Size by Region
3.2.1 Global Sterile Injectable Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Sterile Injectable Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Sterile Injectable Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sterile Injectable Drugs Forecasted Market Size by Region
3.3.1 Global Sterile Injectable Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Sterile Injectable Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Sterile Injectable Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sterile Injectable Drugs by Application
4.1 Sterile Injectable Drugs Market Segment by Application
4.1.1 Cancer
4.1.2 Diabetes
4.1.3 Cardiovascular Diseases
4.1.4 Musculoskeletal
4.1.5 CNS
4.1.6 Infections
4.1.7 Others
4.2 Global Sterile Injectable Drugs Market Size by Application
4.2.1 Global Sterile Injectable Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Sterile Injectable Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sterile Injectable Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sterile Injectable Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sterile Injectable Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sterile Injectable Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sterile Injectable Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sterile Injectable Drugs Sales Breakdown by Application (2018-2023)
5 North America Sterile Injectable Drugs by Country
5.1 North America Sterile Injectable Drugs Historic Market Size by Country
5.1.1 North America Sterile Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sterile Injectable Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Sterile Injectable Drugs Sales in Value by Country (2018-2023)
5.2 North America Sterile Injectable Drugs Forecasted Market Size by Country
5.2.1 North America Sterile Injectable Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Sterile Injectable Drugs Sales in Value by Country (2024-2029)
6 Europe Sterile Injectable Drugs by Country
6.1 Europe Sterile Injectable Drugs Historic Market Size by Country
6.1.1 Europe Sterile Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sterile Injectable Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Sterile Injectable Drugs Sales in Value by Country (2018-2023)
6.2 Europe Sterile Injectable Drugs Forecasted Market Size by Country
6.2.1 Europe Sterile Injectable Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Sterile Injectable Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Sterile Injectable Drugs by Region
7.1 Asia-Pacific Sterile Injectable Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Sterile Injectable Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sterile Injectable Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sterile Injectable Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sterile Injectable Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Sterile Injectable Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sterile Injectable Drugs Sales in Value by Region (2024-2029)
8 Latin America Sterile Injectable Drugs by Country
8.1 Latin America Sterile Injectable Drugs Historic Market Size by Country
8.1.1 Latin America Sterile Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sterile Injectable Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sterile Injectable Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Sterile Injectable Drugs Forecasted Market Size by Country
8.2.1 Latin America Sterile Injectable Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sterile Injectable Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Sterile Injectable Drugs by Country
9.1 Middle East and Africa Sterile Injectable Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Sterile Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sterile Injectable Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sterile Injectable Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sterile Injectable Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Sterile Injectable Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sterile Injectable Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Baxter International
10.1.1 Baxter International Company Information
10.1.2 Baxter International Introduction and Business Overview
10.1.3 Baxter International Sterile Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Baxter International Sterile Injectable Drugs Products Offered
10.1.5 Baxter International Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Sterile Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Sterile Injectable Drugs Products Offered
10.2.5 Sanofi Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Sterile Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Sterile Injectable Drugs Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca Sterile Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AstraZeneca Sterile Injectable Drugs Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Merck
10.5.1 Merck Company Information
10.5.2 Merck Introduction and Business Overview
10.5.3 Merck Sterile Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Merck Sterile Injectable Drugs Products Offered
10.5.5 Merck Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Sterile Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Sterile Injectable Drugs Products Offered
10.6.5 Novartis Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Sterile Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Pfizer Sterile Injectable Drugs Products Offered
10.7.5 Pfizer Recent Development
10.8 GILEAD SCIENCES
10.8.1 GILEAD SCIENCES Company Information
10.8.2 GILEAD SCIENCES Introduction and Business Overview
10.8.3 GILEAD SCIENCES Sterile Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GILEAD SCIENCES Sterile Injectable Drugs Products Offered
10.8.5 GILEAD SCIENCES Recent Development
10.9 Johnson & Johnson Services
10.9.1 Johnson & Johnson Services Company Information
10.9.2 Johnson & Johnson Services Introduction and Business Overview
10.9.3 Johnson & Johnson Services Sterile Injectable Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Johnson & Johnson Services Sterile Injectable Drugs Products Offered
10.9.5 Johnson & Johnson Services Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sterile Injectable Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sterile Injectable Drugs Industrial Chain Analysis
11.4 Sterile Injectable Drugs Market Dynamics
11.4.1 Sterile Injectable Drugs Industry Trends
11.4.2 Sterile Injectable Drugs Market Drivers
11.4.3 Sterile Injectable Drugs Market Challenges
11.4.4 Sterile Injectable Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sterile Injectable Drugs Distributors
12.3 Sterile Injectable Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock